Company Analysis USANA Health Sciences
1. Summary
Advantages
- Price (32.51 $) is less than fair price (44.86 $)
Disadvantages
- Dividends (0%) are below the sector average (2.92%).
- The stock's return over the last year (-35.08%) is lower than the sector average (-9.56%).
- Current debt level 2.09% has increased over 5 years from 1.61%.
- The company's current efficiency (ROE=12.83%) is lower than the sector average (ROE=52.55%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| USANA Health Sciences | Consumer Staples | Index | |
|---|---|---|---|
| 7 days | 0.1% | -7.5% | 0.5% |
| 90 days | -13.6% | -7.8% | -5.3% |
| 1 year | -35.1% | -9.6% | 8.7% |
USNA vs Sector: USANA Health Sciences has significantly underperformed the "Consumer Staples" sector by -25.53% over the past year.
USNA vs Market: USANA Health Sciences has significantly underperformed the market by -43.8% over the past year.
Stable price: USNA is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: USNA with weekly volatility of -0.6747% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (32.51 $) is lower than the fair price (44.86 $).
Price significantly below the fair price: The current price (32.51 $) is 38% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (16.03) is lower than that of the sector as a whole (41.41).
P/E vs Market: The company's P/E (16.03) is lower than that of the market as a whole (73.05).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.06) is lower than that of the sector as a whole (16.39).
P/BV vs Market: The company's P/BV (2.06) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.11) is lower than that of the sector as a whole (4.2).
P/S vs Market: The company's P/S indicator (1.11) is lower than that of the market as a whole (15.91).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (6.22) is lower than that of the sector as a whole (26.36).
EV/Ebitda vs Market: The company's EV/Ebitda (6.22) is lower than that of the market as a whole (23.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -9.77% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-9.77%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (16.21%).
5.4. ROE
ROE vs Sector: The company's ROE (12.83%) is lower than that of the sector as a whole (52.55%).
ROE vs Market: The company's ROE (12.83%) is lower than that of the market as a whole (25.12%).
5.5. ROA
ROA vs Sector: The company's ROA (10.08%) is higher than that of the sector as a whole (8.12%).
ROA vs Market: The company's ROA (10.08%) is higher than that of the market as a whole (6.65%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (26.26%) is higher than that of the sector as a whole (16.22%).
ROIC vs Market: The company's ROIC (26.26%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.92%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
